Monash University and Corvus Pharmaceuticals enter into exclusive license agreement for Novel Immuno-Oncology Program
Monash University and Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, have announced today they have entered into an exclusive agreement. Under the agreement, Corvus has licensed global rights to an undisclosed novel immuno-oncology program, which includes…
Testosterone explains why women more prone to asthma
An international research team has revealed for the first time that testosterone protects males against developing asthma, helping to explain why females are two times more likely to develop asthma than males after puberty. The study showed that…
IDT Receives Victorian Manufacturing Hall of Fame Award for Medical Technologies and Pharmaceuticals
Recognition of excellence in Victorian Advanced Manufacturing 10 May 2017, Melbourne: Australian pharmaceutical manufacturing and drug development company IDT Australia Limited (ASX: IDT) has received a Victorian Manufacturing Hall of Fame award in the High Growth Sector of…
MTPConnect to open 2017 applications for its Project Fund Program
Interested parties encouraged to start preparing their applications to share in the $8.2 million of available funding. MTPConnect – the Industry Growth Centre for medical technology, biotechnology and pharmaceutical (MTP) sector – has announced that the second round…
Landmark Agreement Signed with RMIT for Australian Medicinal Cannabis Initiatives
Leading Australian research university, Royal Melbourne Institute of Technology and MGC Pharmaceuticals have signed a Binding Memorandum of Understanding to collaborate on a full suite of medicinal cannabis research initiatives, initially centred on genetics and cultivation. Under the…
Industry led consortium accelerates regenerative medicine sector
An industry-led consortium is set to begin projects that will link industry partners with regenerative medicine academic research and boost the growth of this emerging sector. The consortium, called the Regenerative Medicine Industry Interface, will accelerate commercialisation and…
New Hudson Institute Director and CEO announced
We are pleased to announce that Professor Elizabeth Hartland has accepted a position as the new Director and CEO of Hudson Institute of Medical Research. Professor Hartland obtained her BSc (Hons) majoring in Microbiology and Biochemistry and subsequently…
BioCurate CEO Appointed
An outstanding industry leader with exceptional national and global experience in successfully propelling important biomedical discoveries out of the lab and into the market has been appointed inaugural CEO of BioCurate Pty Ltd. This AUD $80 million venture…
A Patent Analytics Study on the Australian Advanced Manufacturing Industry
Executive summary Innovation is critical in developing new avenues for economic growth and prosperity for Australia. Innovation can take many different forms and is consequently used and produced by many different businesses. In 2013-14, the manufacturing sector accounted…
2017 Connecting Women – Charity Announced!
The BioMelbourne Network Connecting Women Lunch is now fully booked with over 400 women set to attend on Friday 2nd June. We’re also delighted that we have received a record number of nominations for the BioMelbourne Network Women in Leadership…
More Access To Life-Changing Genomic Testing For Rare Diseases
More Victorian children with rare conditions and diseases will now be able to access world-leading genomic sequencing tests – at no cost – so they can get the diagnosis and treatment they need sooner. The Andrews Labor Government…
New 4D Scanners Give A Clearer Picture Of Lung Health
A world-first scanner – manufactured right here in Victoria – will provide four-dimensional respiratory analysis to better diagnose and treat lung conditions. Visiting Monash University in Clayton today, Minister for Industry and Employment Wade Noonan was given a…
